Deutsche Bank’s XBiotech XBIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-30,338
| Closed | -$98.3K | – | 3756 |
|
|
2025
Q1 | $98.3K | Hold |
30,338
| – | – | ﹤0.01% | 3198 |
|
|
2024
Q4 | $120K | Buy |
+30,338
| New | +$207K | ﹤0.01% | 3244 |
|
|
2022
Q2 | – | Sell |
-8,274
| Closed | -$71K | – | 4349 |
|
|
2022
Q1 | $71K | Sell |
8,274
-978
| -11% | -$9.81K | ﹤0.01% | 3713 |
|
|
2021
Q4 | $103K | Buy |
9,252
+490
| +6% | +$6.38K | ﹤0.01% | 3691 |
|
|
2021
Q3 | $113K | Sell |
8,762
-214
| -2% | -$3.41K | ﹤0.01% | 3848 |
|
|
2021
Q2 | $149K | Sell |
8,976
-289
| -3% | -$4.9K | ﹤0.01% | 3948 |
|
|
2021
Q1 | $159K | Sell |
9,265
-879
| -9% | -$16.4K | ﹤0.01% | 3755 |
|
|
2020
Q4 | $159K | Buy |
10,144
+2,805
| +38% | +$51.7K | ﹤0.01% | 3594 |
|
|
2020
Q3 | $141K | Buy |
7,339
+769
| +12% | +$13.3K | ﹤0.01% | 3396 |
|
|
2020
Q2 | $90K | Buy |
6,570
+1,753
| +36% | +$24.6K | ﹤0.01% | 3489 |
|
|
2020
Q1 | $51K | Sell |
4,817
-2,140
| -31% | -$34.8K | ﹤0.01% | 3539 |
|
|
2019
Q4 | $128K | Buy |
6,957
+957
| +16% | +$12.3K | ﹤0.01% | 3463 |
|
|
2019
Q3 | $62K | Sell |
6,000
-6,559
| -52% | -$53.4K | ﹤0.01% | 3817 |
|
|
2019
Q2 | $94K | Sell |
12,559
-1,772
| -12% | -$15.4K | ﹤0.01% | 4241 |
|
|
2019
Q1 | $157K | Buy |
+14,331
| New | +$116K | ﹤0.01% | 4129 |
|
|
2018
Q4 | – | Sell |
-169
| Closed | -$1K | – | 5447 |
|
|
2018
Q3 | $1K | Sell |
169
-19,203
| -99% | -$74.8K | ﹤0.01% | 5306 |
|
|
2018
Q2 | $87K | Sell |
19,372
-17,070
| -47% | -$77.1K | ﹤0.01% | 4594 |
|
|
2018
Q1 | $194K | Sell |
36,442
-9,235
| -20% | -$42.5K | ﹤0.01% | 4209 |
|
|
2017
Q4 | $179K | Buy |
45,677
+26,608
| +140% | +$112K | ﹤0.01% | 4077 |
|
|
2017
Q3 | $82K | Sell |
19,069
-3,313
| -15% | -$15.6K | ﹤0.01% | 4232 |
|
|
2017
Q2 | $104K | Buy |
22,382
+18,078
| +420% | +$173K | ﹤0.01% | 4191 |
|
|
2017
Q1 | $70K | Sell |
4,304
-6,414
| -60% | -$84K | ﹤0.01% | 4081 |
|
|
2016
Q4 | $107K | Buy |
10,718
+3,994
| +59% | +$53.1K | ﹤0.01% | 4049 |
|
|
2016
Q3 | $89K | Sell |
6,724
-36,556
| -84% | -$536K | ﹤0.01% | 3983 |
|
|
2016
Q2 | $903K | Buy |
43,280
+35,510
| +457% | +$512K | ﹤0.01% | 2964 |
|
|
2016
Q1 | $72K | Buy |
7,770
+4,591
| +144% | +$38K | ﹤0.01% | 4179 |
|
|
2015
Q4 | $33K | Buy |
3,179
+2,067
| +186% | +$26.4K | ﹤0.01% | 4590 |
|
|
2015
Q3 | $16K | Buy |
1,112
+143
| +15% | +$2.5K | ﹤0.01% | 4840 |
|
|
2015
Q2 | $17K | Buy |
+969
| New | +$20.1K | ﹤0.01% | 4951 |
|
Other funds holding XBIT
RC
Deutsche Bank's XBIT Position: Q2 2025 in Review
Deutsche Bank sold out of XBiotech (XBIT) in Q2 2025, closing a stake of 30,338 shares — an estimated $98.3K sold.
Deutsche Bank first reported a position in XBIT in Q2 2015 and held it in 29 quarters. The position peaked at $903K in Q2 2016. 53 funds tracked by Wall St. Rank hold XBIT as of Q2 2025.
- Deutsche Bank reported no remaining XBiotech position as of Q2 2025 after selling out during the quarter.
- Deutsche Bank sold 30,338 XBiotech shares in Q2 2025, an estimated $98.3K.
- Deutsche Bank first reported a position in XBiotech in Q2 2015 and held it in 29 quarters.
- Deutsche Bank's XBiotech position peaked at $903K in Q2 2016.
- 53 funds tracked by Wall St. Rank held XBiotech as of Q2 2025.
Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.